Accelerate Your Biotech Idea Blavatnik and ABCT Info Session

Accelerate Your Biotech Idea Blavatnik and ABCT Info Session

Mary Howard, ABCT

Mary Howard, ABCT

Accelerate Your Biotech Idea Blavatnik and ABCT Info Session

Accelerate Your Biotech Idea Blavatnik and ABCT Info Session

Blavatnik and ABCT Info Session

Blavatnik and ABCT Info Session

John Deacon, Cytosolix

John Deacon, Cytosolix

Mary Howard, ABCT Program Manager

Mary Howard, ABCT Program Manager

Choukri Ben Mamoun, ELiV5 Therapeutics

Choukri Ben Mamoun, ELiV5 Therapeutics

Azeet Narayan, Yale; Mrinal Sanyal, Yale

Azeet Narayan, Yale; Mrinal Sanyal, Yale

John Deacon, Cytosolix

John Deacon, Cytosolix

Mary Howard, ABCT Program Manager

Mary Howard, ABCT Program Manager

Blavatnik and ABCT Info Session

Blavatnik and ABCT Info Session

Mary Howard, ABCT Program Manager

Mary Howard, ABCT Program Manager

Bill Wiesler, Blavatnik Fund for Innovation at Yale

Bill Wiesler, Blavatnik Fund for Innovation at Yale

Mary Howard, ABCT Program Manager

Mary Howard, ABCT Program Manager

Baosong Wu, Yale

Baosong Wu, Yale

Choukri Ben Mamoun, ELiV5 Therapeutics

Choukri Ben Mamoun, ELiV5 Therapeutics

John Deacon, Cytosolix

John Deacon, Cytosolix

Baosong Wu, Yale

Baosong Wu, Yale

Mary Howard, ABCT Program and Bill Wiesler, Blavatnik Fund for Innovation at Yale

Mary Howard, ABCT Program and Bill Wiesler, Blavatnik Fund for Innovation at Yale

Choukri Ben Mamoun, ELiV5 Therapeutics

Choukri Ben Mamoun, ELiV5 Therapeutics

Choukri Ben Mamoun, ELiV5 Therapeutics

Choukri Ben Mamoun, ELiV5 Therapeutics

John Deacon, Cytosolix; Choukri Ben Mamoun, ELiV5 Therapeutics

John Deacon, Cytosolix; Choukri Ben Mamoun, ELiV5 Therapeutics

Mary Howard, ABCT Program Manager

Mary Howard, ABCT Program Manager

Blavatnik and ABCT Info Session

Blavatnik and ABCT Info Session

Azeet Narayan, Yale; Mrinal Sanyal, Yale

Azeet Narayan, Yale; Mrinal Sanyal, Yale

John Deacon, Cytosolix

John Deacon, Cytosolix

Mary Howard, ABCT; Choukri Ben Mamoun, ELiV5 Therapeutics; John Deacon, Cytosolix

Mary Howard, ABCT; Choukri Ben Mamoun, ELiV5 Therapeutics; John Deacon, Cytosolix

Accelerator for Biosciences in Connecticut

Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBA's and MD's interested to form new ventures in biosciences.

Accelerator for Biosciences in Connecticut encourages applications from IP based inventions. You do not need a company formed to apply to ABCT. ABCT features a mini-MBA curriculum, expert coaching, networking, mentorship, pitch preparation, access to professional colleagues as Venture Advisors from the program Corporate Supporters including Purdue, Kaneka, Pfizer, Marcum, Shipman & Goodwin, WSGR, Wiggin and Dana and AON and access to the NYC biosciences community including foundations and investors.

Corporate Supporters

ABCT is a Program of

An intiative of

Copyright © 2018 Accelerator for Biosciences in Connecticut